Glucose Health, Inc. SEC filings GLUC
Glucose Health, Inc. has 140 filings in SEC EDGAR's recent list, going back to Dec 7, 2007. Its latest annual report, Form 10-K, was filed on Mar 29, 2017 for the period ended Dec 31, 2016. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2017, covering the quarter ended Sep 30, 2017. The most recent current report (Form 8-K) was filed on Apr 11, 2017 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Auditor change
|
Apr 11, 2017 | Apr 6, 2017 |
| 8-K |
Current report
Other events
|
Mar 11, 2016 | Jan 6, 2016 |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2016 | Feb 5, 2016 |
| 8-K |
Current report
Other events
|
Jan 27, 2016 | Jan 27, 2016 |
| 8-K |
Current report
Auditor change
|
Aug 6, 2015 | Jun 30, 2015 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2015 | Feb 10, 2015 |
| 8-K |
Current report
Other events
|
Dec 16, 2014 | Dec 15, 2014 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 10, 2014 | Nov 5, 2014 |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Change in control, Officer or director change
|
Oct 23, 2014 | Oct 1, 2014 |
| 8-K |
Current report
Auditor change
|
Oct 7, 2014 | Oct 3, 2014 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Oct 2, 2014 | Oct 1, 2014 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2014 | Jul 22, 2014 |
| 8-K |
Current report
Auditor change
|
May 5, 2014 | Apr 30, 2014 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2014 | Apr 21, 2014 |
| 8-K |
Current report
Material agreement, Agreement ended, Officer or director change, Bylaw or fiscal year change
|
Apr 15, 2014 | Dec 19, 2013 |
| 8-K |
Current report
Material agreement
|
Aug 6, 2013 | Aug 1, 2013 |
| 8-K |
Current report
Officer or director change
|
Jun 26, 2012 | Jun 20, 2012 |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2012 | Feb 15, 2012 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Nov 22, 2011 | Sep 26, 2011 |
| 8-K |
Current report
Officer or director change
|
Nov 16, 2011 | Oct 10, 2011 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 25, 2010 | Jun 25, 2010 |
| 8-K |
Current report
Material agreement
|
Aug 18, 2009 | Aug 17, 2009 |
| 8-K |
Current report
Officer or director change
|
Mar 18, 2009 | Mar 16, 2009 |
| 8-K |
Current report
Unregistered share sale
|
Dec 23, 2008 | Dec 18, 2008 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 16, 2008 | Sep 3, 2008 |
| 8-K |
Current report
Auditor change
|
Feb 1, 2008 | Jan 29, 2008 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- GLUC (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bentonville, AR
- SEC filer status
- Smaller reporting company
- SEC CIK
- 1420108
- Former names
- Bio-Solutions Corp. (until Dec 16, 2014)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.